Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bonnet

Showing results (471-480 of 546) with videos related to

Pageof 55
Sort By:
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapyM Savès, P Morlat, G Chêne, et al.
Presse Medicale (Paris, France : 1983)|January 11, 2005
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]T May, C Lewden, F Bonnet, et al.
Anesthesiology|July 1, 1989
Abnormalities in myocardial segmental wall motion during lumbar epidural anesthesiaM Saada, A M Duval, F Bonnet, et al.
Human Genetics|April 1, 1989
Localization of human platelet proteoglycan gene to chromosome 10, band q22.1, by in situ hybridizationM G Mattei, J P Périn, P M Alliel, et al.
HIV Medicine|July 26, 2002
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999F Bonnet, P Morlat, G Chêne, et al.
Diagnostic and Interventional Imaging|March 17, 2012
Functional morphological imaging of autism spectrum disorders: current position and theories proposedM-A Lauvin, J Martineau, C Destrieux, et al.
Transplantation|April 1, 1993
Tumor necrosis factor alpha in human kidney transplant rejection--analysis by in situ hybridizationD Morel, E Normand, C Lemoine, et al.
Journal of Clinical Immunology|May 10, 2002
Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAARTF Bonnet, M Savès, P H Morlat, et al.
HIV Medicine|May 7, 2005
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002F Bonnet, R Thiébaut, G Chêne, et al.
Diabetes & Metabolism|November 24, 2011
Expert consensus on management of diabetic patients with impairment of renal functionF Bonnet, E Gauthier, H Gin, et al.
Pageof 55

Showing results (471-480 of 546) with videos related to

Sort By:
Pageof 55
Clinical Immunology (Orlando, Fla.)|May 19, 2001
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapyM Savès, P Morlat, G Chêne, et al.
Presse Medicale (Paris, France : 1983)|January 11, 2005
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]T May, C Lewden, F Bonnet, et al.
Anesthesiology|July 1, 1989
Abnormalities in myocardial segmental wall motion during lumbar epidural anesthesiaM Saada, A M Duval, F Bonnet, et al.
Human Genetics|April 1, 1989
Localization of human platelet proteoglycan gene to chromosome 10, band q22.1, by in situ hybridizationM G Mattei, J P Périn, P M Alliel, et al.
HIV Medicine|July 26, 2002
Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999F Bonnet, P Morlat, G Chêne, et al.
Diagnostic and Interventional Imaging|March 17, 2012
Functional morphological imaging of autism spectrum disorders: current position and theories proposedM-A Lauvin, J Martineau, C Destrieux, et al.
Transplantation|April 1, 1993
Tumor necrosis factor alpha in human kidney transplant rejection--analysis by in situ hybridizationD Morel, E Normand, C Lemoine, et al.
Journal of Clinical Immunology|May 10, 2002
Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAARTF Bonnet, M Savès, P H Morlat, et al.
HIV Medicine|May 7, 2005
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002F Bonnet, R Thiébaut, G Chêne, et al.
Diabetes & Metabolism|November 24, 2011
Expert consensus on management of diabetic patients with impairment of renal functionF Bonnet, E Gauthier, H Gin, et al.
Pageof 55